Skip to main content
SpringerLink
Log in

Cardiovascular FDG-PET Atlas of Cases

  • Chapter
  • First Online:
FDG-PET/CT and PET/MR in Cardiovascular Diseases

  • 305 Accesses

Abstract

An 85-year-old male had a history of type 2 diabetes mellitus, polycystic kidney disease, hypertension, atrial fibrillation (AF), and nonischemic cardiomyopathy with a left ventricular ejection fraction (LVEF) of 25% and a biventricular pacemaker (CRT-D) presented to the ER in septic shock with an infection of unknown origin. He reported coughing with worsening dyspnea and new-onset back pain in the preceding weeks. Blood cultures were positive for Salmonella group D. Chest radiographs showed a left perihilar infiltration. Transoesophageal echocardiogram (TEE) demonstrated thickening of the right atrium lead with a mobile millimetric mass, suggesting either a thrombus or a vegetation (Fig. 24.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AF:

Atrial fibrillation

AFB:

Acid-fast bacillus

AV block:

Atrioventricular block

CAD:

Coronary artery disease

CCTA:

Coronary computed tomography angiography

CIED:

Cardiac implantable electronic device

CIED-LI:

Cardiac implantable electronic device lead infection

COPD:

Chronic obstructive pulmonary

CRP:

C-reactive protein

CS:

Cardiac sarcoidosis

CT:

Computed tomography

CTA:

Computed tomography angiography

CTPA:

Computed tomography pulmonary angiography

DES:

Drug-eluting stent

DSWI:

Deep sternal wound infection

ECMO:

Extracorporeal membrane oxygenation

ER:

Emergency room

FDG:

18F-fluorodeoxyglucose

GCA:

Giant-cell arteritis

GPI:

Generator pocket infection

HRS:

Heart and Rhythm Society

hs-cTnT:

High-sensitivity cardiac troponin T

ICD:

Implantable cardioverter-defibrillator

IE:

Infective endocarditis

JCS:

Japan Circulation Society

LAD:

Left anterior descending coronary artery

LDCT:

Low-dose CT scan

LVEF:

Left ventricular ejection fraction

LVV:

Large-vessel

MPA:

Main pulmonary artery

MPI:

Myocardial perfusion imaging

MRI:

Magnetic resonance imaging

MSSA:

Methicillin-susceptible Staphylococcus aureus

NVE:

Native valve infective endocarditis

PAS:

Pulmonary artery sarcoma

PE:

Pulmonary emboli

PET:

Positron emission tomography

PICC:

Peripherally inserted central catheter

PVE:

Prosthetic valve infective endocarditis

82Rb:

Rubidium-82

RCA:

Right coronary artery

RHS:

Right heart strain

RUL:

Right upper lobe

SSWI:

Superficial sternal wound infection

STEMI:

ST-elevation myocardial infarction

SUV:

Standardized uptake value

SWI:

Sternal wound infection

TAK:

Takayasu arteritis

TAVR:

Transcatheter aortic valve replacement

TEE:

Transoesophageal echocardiogram

TTE:

Transthoracic echocardiogram

VG:

Vascular graft

VGI:

Vascular graft infection

VSD:

Ventricular septal defect

WBC:

White blood cell

References

  1. Husmann L, Huellner MW, Ledergerber B, Eberhard N, Kaelin MB, Anagnostopoulos A, et al. Diagnostic accuracy of PET/CT and contrast enhanced CT in patients with suspected infected aortic aneurysms. Eur J Vasc Endovasc Surg. 2020;59(6):972–81.

    Article  PubMed  Google Scholar 

  2. Macedo TA, Stanson AW, Oderich GS, Johnson CM, Panneton JM, Tie ML. Infected aortic aneurysms: imaging findings. Radiology. 2004;231(1):250–7.

    Article  PubMed  Google Scholar 

  3. Murakami M, Morikage N, Samura M, Yamashita O, Suehiro K, Hamano K. Fluorine-18-fluorodeoxyglucose positron emission tomography–computed tomography for diagnosis of infected aortic aneurysms. Ann Vasc Surg. 2014;28(3):575–8.

    Article  PubMed  Google Scholar 

  4. Murphy DJ, Keraliya AR, Agrawal MD, Aghayev A, Steigner ML. Cross-sectional imaging of aortic infections. Insights Imaging. 2016;7(6):801–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128.

    Article  PubMed  Google Scholar 

  6. Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61(23):2374–82.

    Article  PubMed  Google Scholar 

  7. Erba PA, Sollini M, Lazzeri E, Mariani G. FDG-PET in cardiac infections. Semin Nucl Med. 2013;43(5):377–95.

    Article  PubMed  Google Scholar 

  8. Salaun E, Sportouch L, Barral P-A, Hubert S, Lavoute C, Casalta A-C, et al. Diagnosis of infective endocarditis after TAVR: value of a multimodality imaging approach. JACC Cardiovasc Imaging. 2018;11(1):143–6.

    Article  PubMed  Google Scholar 

  9. Swart LE, Scholtens AM, Liesting C, van Mieghem NMDA, Krestin GP, Roos-Hesselink JW, et al. Serial 18F-fluorodeoxyglucose positron emission tomography/CT angiography in transcatheter-implanted aortic valve endocarditis. Eur Heart J. 2016;37(39):3059.

    Article  PubMed  Google Scholar 

  10. Roque A, Pizzi MN. 18F-FDG PET/CT and cardiac CTA in transcatheter aortic valve implanted endocarditis: still at the beginning of a long road. J Nucl Cardiol. 2021;28(5):2083–5.

    Article  PubMed  Google Scholar 

  11. Wahadat AR, Tanis W, Swart LE, Scholtens A, Krestin GP, van Mieghem NMDA, et al. Added value of 18F-FDG-PET/CT and cardiac CTA in suspected transcatheter aortic valve endocarditis. J Nucl Cardiol. 2021;28(5):2072–82.

    Article  PubMed  Google Scholar 

  12. Randhawa K, Ganeshan A, Hoey ETD. Magnetic resonance imaging of cardiac tumors: part 2, malignant tumors and tumor-like conditions. Curr Probl Diagn Radiol. 2011;40(4):169–79.

    Article  PubMed  Google Scholar 

  13. Saponara M, Ambrosini V, Nannini M, Gatto L, Astolfi A, Urbini M, et al. 18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. Ther Adv Med Oncol. 2018;10:1758835918793569.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Silvestri F, Bussani R, Pavletic N, Mannone T. Metastases of the heart and pericardium. G Ital Cardiol. 1997;27(12):1252–5.

    CAS  PubMed  Google Scholar 

  15. Hoffmann U, Globits S, Schima W, Loewe C, Puig S, Oberhuber G, et al. Usefulness of magnetic resonance imaging of cardiac and paracardiac masses. Am J Cardiol. 2003;92(7):890–5.

    Article  PubMed  Google Scholar 

  16. Martineau P, Dilsizian V, Pelletier-Galarneau M. Incremental value of FDG-PET in the evaluation of cardiac masses. Curr Cardiol Rep. 2021;23(7):78.

    Article  PubMed  Google Scholar 

  17. Søgaard KK, Farkas DK, Ehrenstein V, Bhaskaran K, Bøtker HE, Sørensen HT. Pericarditis as a marker of occult cancer and a prognostic factor for cancer mortality. Circulation. 2017;136(11):996–1006.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Burazor I, Imazio M, Markel G, Adler Y. Malignant pericardial effusion. Cardiology. 2013;124(4):224–32.

    Article  CAS  PubMed  Google Scholar 

  19. Quint LE. Thoracic complications and emergencies in oncologic patients. Cancer Imaging. 2009;9(Special issue A):S75–82.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Mainzer G, Zaidman I, Hatib I, Lorber A. Intrapericardial steroid treatment for recurrent pericardial effusion in a patient with acute lymphoblastic leukaemia. Hematol Oncol. 2011;29(4):220–1.

    Article  PubMed  Google Scholar 

  21. Kim M-S, Kim E-K, Choi JY, Oh JK, Chang S-A. Clinical utility of [18F]FDG-PET/CT in pericardial disease. Curr Cardiol Rep. 2019;21(9):107.

    Article  PubMed  Google Scholar 

  22. Chang S-A, Choi JY, Kim EK, Hyun SH, Jang SY, Choi J-O, et al. [18F]Fluorodeoxyglucose PET/CT predicts response to steroid therapy in constrictive pericarditis. J Am Coll Cardiol. 2017;69(6):750–2.

    Article  PubMed  Google Scholar 

  23. Pelletier-Galarneau M, Abikhzer G, Harel F, Dilsizian V. Detection of native and prosthetic valve endocarditis: incremental attributes of functional FDG PET/CT over morphologic imaging. Curr Cardiol Rep. 2020;22(9):93.

    Article  PubMed  Google Scholar 

  24. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–8.

    Article  CAS  PubMed  Google Scholar 

  25. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for infection and cancer. Eur Heart J. 2009;30(19):2369–413.

    Article  PubMed  Google Scholar 

  26. Bensimhon L, Lavergne T, Hugonnet F, Mainardi J-L, Latremouille C, Maunoury C, et al. Whole body [18F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study. Clin Microbiol Infect. 2011;17(6):836–44.

    Article  CAS  PubMed  Google Scholar 

  27. Ploux S, Riviere A, Amraoui S, Whinnett Z, Barandon L, Lafitte S, et al. Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm. 2011;8(9):1478–81.

    Article  PubMed  Google Scholar 

  28. Pizzi MN, Roque A, Fernández-Hidalgo N, Cuéllar-Calabria H, Ferreira-González I, Gonzàlez-Alujas MT, et al. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-Fluordeoxyglucose positron emission tomography/computed tomography angiography. Circulation. 2015;132(12):1113–26.

    Article  PubMed  Google Scholar 

  29. Bonfiglioli R, Nanni C, Morigi JJ, Graziosi M, Trapani F, Bartoletti M, et al. 18F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. Eur J Nucl Med Mol Imaging. 2013;40(8):1190–6.

    Article  CAS  PubMed  Google Scholar 

  30. Stamatis P. Giant cell arteritis versus takayasu arteritis: an update. Mediterr J Rheumatol. 2020;31(2):174–82.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Pelletier-Galarneau M, Ruddy TD. Molecular imaging of coronary inflammation. Trends Cardiovasc Med. 2019;29(4):191–7.

    Article  PubMed  Google Scholar 

  32. Cohen Tervaert JW. Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides. Best Pract Res Clin Rheumatol. 2013;27(1):33–44.

    Article  PubMed  Google Scholar 

  33. Matthew J. Koster, Kenneth J. Warrington. Vasculitis of the coronary arteries. Am Coll Cardiol. 2022. https://www.acc.org/latest-in-cardiology/articles/2019/03/13/06/50/http%3a%2f%2fwww.acc.org%2flatest-in-cardiology%2farticles%2f2019%2f03%2f13%2f06%2f50%2fvasculitis-of-the-coronary-arteries.

  34. Mukhtyar C, Brogan P, Luqmani R. Cardiovascular involvement in primary systemic vasculitis. Best Pract Res Clin Rheumatol. 2009;23(3):419–28.

    Article  PubMed  Google Scholar 

  35. Pelletier-Galarneau M, Ruddy TD. PET/CT for diagnosis and management of large-vessel vasculitis. Curr Cardiol Rep. 2019;21(5):34.

    Article  PubMed  Google Scholar 

  36. Lensen KDF, Comans EFI, Voskuyl AE, van der Laken CJ, Brouwer E, Zwijnenburg AT, et al. Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT. Biomed Res Int. 2015;2015:e914692.

    Article  Google Scholar 

  37. de Boysson H, et al. Repetitive 18F-FDG-PET/CT in patients with large-vessel giant-cell arteritis and controlled disease. Eur J Intern Med. 2022;46:66–70. https://www.ejinme.com/article/S0953-6205(17)30315-1/fulltext.

    Article  Google Scholar 

  38. Bax JJ, Cornel JH, Visser FC, Fioretti PM, van Lingen A, Huitink JM, et al. Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization. J Nucl Med. 1998;39(9):1481–6.

    CAS  PubMed  Google Scholar 

  39. Bax JJ, Patton JA, Poldermans D, Elhendy A, Sandler MP. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications. Semin Nucl Med. 2000;30(4):281–98.

    Article  CAS  PubMed  Google Scholar 

  40. Schinkel AFL, Poldermans D, Elhendy A, Bax JJ. Assessment of myocardial viability in patients with heart failure. J Nucl Med. 2007;48(7):1135–46.

    Article  PubMed  Google Scholar 

  41. Grandin C, Wijns W, Melin JA, Bol A, Robert AR, Heyndrickx GR, et al. Delineation of myocardial viability with PET. J Nucl Med. 1995;36(9):1543–52.

    CAS  PubMed  Google Scholar 

  42. Gropler RJ, Siegel BA, Sampathkumaran K, Pérez JE, Sobel BE, Bergmann SR, et al. Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. J Am Coll Cardiol. 1992;19(5):989–97.

    Article  CAS  PubMed  Google Scholar 

  43. Schwaiger M, Brunken R, Grover-McKay M, Krivokapich J, Child J, Tillisch JH, et al. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol. 1986;8(4):800–8.

    Article  CAS  PubMed  Google Scholar 

  44. Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40(39):3222–32.

    Article  PubMed  Google Scholar 

  45. Ahmed FZ, Arumugam P. 18F-FDG PET/CT now endorsed by guidelines across all types of CIED infection: evidence limited but growing. J Nucl Cardiol. 2019;26(3):971–4.

    Article  PubMed  Google Scholar 

  46. Juneau D, Golfam M, Hazra S, Zuckier LS, Garas S, Redpath C, et al. Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device infection. Circ Cardiovasc Imaging. 2017;10(4):e005772.

    Article  PubMed  Google Scholar 

  47. Mahmood M, Kendi AT, Farid S, Ajmal S, Johnson GB, Baddour LM, et al. Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: a meta-analysis. J Nucl Cardiol. 2019;26(3):958–70.

    Article  PubMed  Google Scholar 

  48. Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 1995;92(12):3436–44.

    Article  PubMed  Google Scholar 

  49. Maddahi J. Factors influencing predictive value of fdg imaging for evaluating myocardial viability. J Nucl Cardiol. 2004;11(5):524–6.

    Article  PubMed  Google Scholar 

  50. Schöder H, Campisi R, Ohtake T, Hoh CK, Moon DH, Czernin J, et al. Blood flow–metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction. The Laboratory of Structural Biology and Molecular Medicine is operated for the U.S. Department of Energy by the University of California under Contract #DE-FC03-87ER60615. J Am Coll Cardiol. 1999;33(5):1328–37.

    Article  PubMed  Google Scholar 

  51. Singh D, Foessel R, Nagra N, Lau P, Brauchli D. Acute saddle pulmonary embolism on 18F-FDG PET/CT: diagnosis by functional imaging. Respirol Case Rep. 2019;7(8):e00476.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Franceschi AM, Matthews R, Mankes S, Safaie E, Franceschi D. Four chamber FDG uptake in the heart: an indirect sign of pulmonary embolism. Clin Nucl Med. 2012;37(7):687–91.

    Article  PubMed  Google Scholar 

  53. Flavell RR, Behr SC, Brunsing RL, Naeger DM, Pampaloni MH. The incidence of pulmonary embolism and associated FDG-PET findings in IV contrast-enhanced PET/CT. Acad Radiol. 2014;21(6):718–25.

    Article  PubMed  Google Scholar 

  54. Soussan M, Rust E, Pop G, Morère J-F, Brillet P-Y, Eder V. The rim sign: FDG-PET/CT pattern of pulmonary infarction. Insights Imaging. 2012;3(6):629–33.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Wittram C, Scott JA. 18F-FDG PET of pulmonary embolism. Am J Roentgenol. 2007;189(1):171–6.

    Article  Google Scholar 

  56. Bastiaannet E, Groen H, Jager PL, Cobben DCP, van der Graaf WTA, Vaalburg W, et al. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev. 2004;30(1):83–101.

    Article  CAS  PubMed  Google Scholar 

  57. Thurer RL, Thorsen A, Parker JA, Karp DD. FDG imaging of a pulmonary artery sarcoma. Ann Thorac Surg. 2000;70(4):1414–5.

    Article  CAS  PubMed  Google Scholar 

  58. Chong S, Kim TS, Kim B-T, Cho EY, Kim J. Pulmonary Artery Sarcoma mimicking pulmonary thromboembolism: integrated FDG PET/CT. Am J Roentgenol. 2007;188(6):1691–3.

    Article  Google Scholar 

  59. Tueller C, Fischer Biner R, Minder S, Gugger M, Stoupis C, Krause TM, et al. FDG-PET in diagnostic work-up of pulmonary artery sarcomas. Eur Respir J. 2010;35(2):444–6.

    Article  CAS  PubMed  Google Scholar 

  60. Pelletier-Galarneau M, Juneau D. Vascular graft infection: improving diagnosis with functional imaging. J Nucl Cardiol. 2020. https://doi.org/10.1007/s12350-020-02269-z.

  61. Lyons OTA, Baguneid M, Barwick TD, Bell RE, Foster N, Homer-Vanniasinkam S, et al. Diagnosis of aortic graft infection: a case definition by the Management of Aortic Graft Infection Collaboration (MAGIC). Eur J Vasc Endovasc Surg. 2016;52(6):758–63.

    Article  CAS  PubMed  Google Scholar 

  62. Rojoa D, Kontopodis N, Antoniou SA, Ioannou CV, Antoniou GA. 18F-FDG PET in the diagnosis of vascular prosthetic graft infection: a diagnostic test accuracy meta-analysis. Eur J Vasc Endovasc Surg. 2019;57(2):292–301.

    Article  PubMed  Google Scholar 

  63. Sarrazin J-F, Trottier M, Tessier M. How useful is 18F-FDG PET/CT in patients with suspected vascular graft infection? J Nucl Cardiol. 2020;27(1):303–4.

    Article  PubMed  Google Scholar 

  64. Lucinian YA, Lamarche Y, Demers P, Martineau P, Harel F, Pelletier-Galarneau M. FDG-PET/CT for the detection of infection following aortic root replacement surgery. JACC Cardiovasc Imaging. 2020;13(6):1447–9.

    Article  PubMed  Google Scholar 

  65. Kim S-J, Lee S-W, Jeong SY, Pak K, Kim K. A systematic review and meta-analysis of 18F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography for detection of infected prosthetic vascular grafts. J Vasc Surg. 2019;70(1):307–13.

    Article  PubMed  Google Scholar 

  66. Reinders Folmer EI, Von Meijenfeldt GCI, Van der Laan MJ, Glaudemans AWJM, Slart RHJA, Saleem BR, et al. Diagnostic imaging in vascular graft infection: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2018;56(5):719–29.

    Article  PubMed  Google Scholar 

  67. Lazar HL, Salm TV, Engelman R, Orgill D, Gordon S. Prevention and management of sternal wound infections. J Thorac Cardiovasc Surg. 2016;152(4):962–72.

    Article  PubMed  Google Scholar 

  68. Hever P, Singh P, Eiben I, Eiben P, Nikkhah D. The management of deep sternal wound infection: literature review and reconstructive algorithm. JPRAS Open. 2021;28:77–89.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Hariri H, Tan S, Martineau P, Lamarche Y, Carrier M, Finnerty V, et al. FDG-PET/CT for the assessment of sternal wound infection following sternotomy. J Nucl Med. 2019;60(supplement 1):223.

    Google Scholar 

  70. Zhang R, Feng Z, Zhang Y, Tan H, Wang J, Qi F. Diagnostic value of fluorine-18 deoxyglucose positron emission tomography/computed tomography in deep sternal wound infection. J Plast Reconstr Aesthet Surg. 2018;71(12):1768–76.

    Article  PubMed  Google Scholar 

  71. Liu S, Zhang J, Yin H, Pang L, Wu B, Shi H. The value of 18F-FDG PET/CT in diagnosing and localising deep sternal wound infection to guide surgical debridement. Int Wound J. 2020;17(4):1019–27.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Nensa F, Tezgah E, Poeppel TD, Jensen CJ, Schelhorn J, Köhler J, et al. Integrated18F-FDG PET/MR Imaging in the assessment of cardiac masses: a pilot study. J Nucl Med. 2015;56(2):255–60.

    Article  PubMed  Google Scholar 

  73. Gowda RM, Khan IA, Nair CK, Mehta NJ, Vasavada BC, Sacchi TJ. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003;146(3):404–10.

    Article  PubMed  Google Scholar 

  74. Ibrahim M, Masters RG, Hynes M, Veinot JP, Davies RA. Papillary fibroelastoma of the pulmonary valve. Can J Cardiol. 2006;22(6):509–10.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Skali H, Schulman AR, Dorbala S. 18F-FDG PET/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep. 2013;15(4):352.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Manabe O, Ohira H, Yoshinaga K, Sato T, Klaipetch A, Oyama-Manabe N, et al. Elevated 18F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis. Eur J Nucl Med Mol Imaging. 2013;40(10):1558–66.

    Article  CAS  PubMed  Google Scholar 

  77. Martineau P, Pelletier-Galarneau M, Juneau D, Leung E, Birnie D, Beanlands RSB. Molecular imaging of cardiac sarcoidosis. Curr Cardiovasc Imaging Rep. 2018;11(3):6.

    Article  Google Scholar 

  78. Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis-digest version. Circ J. 2019;83(11):2329–88.

    Article  PubMed  Google Scholar 

  79. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305–23.

    Article  PubMed  Google Scholar 

  80. Birnie DH, Nery PB, Ha AC, Beanlands RSB. Cardiac sarcoidosis. J Am Coll Cardiol. 2016;68(4):411–21.

    Article  PubMed  Google Scholar 

  81. Shelke AB, Aurangabadkar HU, Bradfield JS, Ali Z, Kumar KS, Narasimhan C. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis. Int J Cardiol. 2017;228:717–22.

    Article  PubMed  Google Scholar 

  82. Lee P-I, Cheng G, Alavi A. The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis. J Nucl Cardiol. 2017;24(1):19–28.

    Article  PubMed  Google Scholar 

  83. Ning N, Guo HH, Iagaru A, Mittra E, Fowler M, Witteles R. Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis. J Card Fail. 2019;25(4):307–11.

    Article  PubMed  Google Scholar 

  84. Ahmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis. J Nucl Cardiol. 2017;24(2):413–24.

    Article  PubMed  Google Scholar 

  85. Ishiyama M, Soine LA, Vesselle HJ. Semi-quantitative metabolic values on FDG PET/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis. EJNMMI Res. 2017;7(1):67.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Abikhzer G, Martineau P, Grégoire J, Finnerty V, Harel F, Pelletier-Galarneau M. [18F]FDG-PET CT for the evaluation of native valve endocarditis. J Nucl Cardiol. 2020;29(1):158–65. https://doi.org/10.1007/s12350-020-02092-6.

    Article  PubMed  Google Scholar 

  87. Chang S-A. Tuberculous and infectious pericarditis. Cardiol Clin. 2017;35(4):615–22.

    Article  PubMed  Google Scholar 

  88. Sagristà-Sauleda J, Permanyer-Miralda G, Soler-Soler J. Tuberculous pericarditis: ten year experience with a prospective protocol for diagnosis and treatment. J Am Coll Cardiol. 1988;11(4):724–8.

    Article  PubMed  Google Scholar 

  89. Dong A, Dong H, Wang Y, Cheng C, Zuo C, Lu J. (18)F-FDG PET/CT in differentiating acute tuberculous from idiopathic pericarditis: preliminary study. Clin Nucl Med. 2013;38(4):e160–5.

    Article  PubMed  Google Scholar 

  90. Vorster M, Sathekge MM, Bomanji J. Advances in imaging of tuberculosis: the role of 18F-FDG PET and PET/CT. Curr Opin Pulm Med. 2014;20(3):287–93.

    Article  PubMed  Google Scholar 

  91. Sathekge MM, Maes A, Pottel H, Stoltz A, van de Wiele C. Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area. South Afr Med J. 2010;100(9):598–601.

    Article  Google Scholar 

  92. Pelletier-Galarneau M, Martineau P, Zuckier LS, Pham X, Lambert R, Turpin S. 18F-FDG-PET/CT imaging of thoracic and extrathoracic tuberculosis in children. Semin Nucl Med. 2017;47(3):304–18.

    Article  PubMed  Google Scholar 

  93. Ha J-W, Lee J-D, Ko Y-G, Yun M, Rim S-J, Chung N, et al. Assessment of pericardial inflammation in a patient with tuberculous effusive constrictive pericarditis with 18F-2-deoxyglucose positron emission tomography. Circulation. 2006;113(1):e4–5.

    Article  PubMed  Google Scholar 

  94. Testempassi E, Kubota K, Morooka M, Ito K, Masuda-Miyata Y, Yamashita H, et al. Constrictive tuberculous pericarditis diagnosed using 18F-fluorodeoxyglucose positron emission tomography: a report of two cases. Ann Nucl Med. 2010;24(5):421–5.

    Article  PubMed  Google Scholar 

  95. Kim SM, Park S-J, Park JR, Choi JH, Yang JH, Noh HJ, et al. A newly developed pericardial tuberculoma during antituberculous therapy. Korean Circ J. 2011;41(12):750–3.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Montreal Heart Institute, Montréal, QC, Canada

    Yousif A. Lucinian & Matthieu Pelletier-Galarneau

  2. BC Cancer Agency, Vancouver, BC, Canada

    Patrick Martineau

Authors
  1. Yousif A. Lucinian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick Martineau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthieu Pelletier-Galarneau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthieu Pelletier-Galarneau .

Editor information

Editors and Affiliations

  1. Montreal Heart Institute, Montréal, QC, Canada

    Matthieu Pelletier-Galarneau

  2. BC Cancer Agency, Vancouver, BC, Canada

    Patrick Martineau

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lucinian, Y.A., Martineau, P., Pelletier-Galarneau, M. (2022). Cardiovascular FDG-PET Atlas of Cases. In: Pelletier-Galarneau, M., Martineau, P. (eds) FDG-PET/CT and PET/MR in Cardiovascular Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-09807-9_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-09807-9_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-09806-2

  • Online ISBN: 978-3-031-09807-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation